Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells

Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells

Item
http://www.wikidata.org/entity/Q28533484
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancerSorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cellsSorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cellsEpigenetic Profiling of H3K4Me3 Reveals Herbal Medicine Jinfukang-Induced Epigenetic Alteration Is Involved in Anti-Lung Cancer Activity.Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.Clinical significance of epithelial-mesenchymal transition.EMT: Present and future in clinical oncology.Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition.EMT and tumor metastasisNRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.Clinicopathological examination of dipeptidase 1 expression in colorectal cancer.Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer.Effects of Antitumor Drug Sorafenib on Chick Embryo Development.
P2860

Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells

Item
http://www.wikidata.org/entity/Q28533484
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@ast
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@en
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@nl
type
label
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@ast
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@en
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@nl
prefLabel
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@ast
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@en
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Sorafenib inhibits epithelial- ...... in human lung epithelial cells
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0064954
P407
P433
P478
P50
P577
P5875
P698
P932